(0.33%) 5 117.02 points
(0.33%) 38 365 points
(0.37%) 15 987 points
(-0.99%) $83.02
(5.56%) $2.03
(0.34%) $2 355.20
(0.48%) $27.67
(4.05%) $959.45
(-0.26%) $0.932
(-0.41%) $10.98
(-0.57%) $0.796
(1.69%) $93.43
@ $0.773
発行日: 15 2月 2024 @ 05:29
リターン: -33.28%
前回のシグナル: 2月 15 - 00:21
前回のシグナル:
リターン: 3.62 %
Live Chart Being Loaded With Signals
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics...
Stats | |
---|---|
本日の出来高 | 3.28M |
平均出来高 | 7.57M |
時価総額 | 248.99M |
EPS | $0 ( 2024-02-07 ) |
次の収益日 | ( $-0.150 ) 2024-05-26 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.460 |
ATR14 | $0.00300 (0.58%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-18 | Hibbs Kathy L | Buy | 38 548 | Class A Common Stock |
2024-04-18 | Hibbs Kathy L | Sell | 38 548 | Class A Common Stock |
2024-04-18 | Hibbs Kathy L | Sell | 38 548 | Stock Option (Right to Buy) |
2024-04-04 | Hibbs Kathy L | Buy | 38 548 | Class A Common Stock |
2024-04-04 | Hibbs Kathy L | Sell | 38 548 | Class A Common Stock |
INSIDER POWER |
---|
73.77 |
Last 100 transactions |
Buy: 15 283 999 | Sell: 2 077 892 |
ボリューム 相関
23andMe Holding Co. 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
23andMe Holding Co. 相関 - 通貨/商品
23andMe Holding Co. 財務諸表
Annual | 2022 |
収益: | $299.49M |
総利益: | $134.50M (44.91 %) |
EPS: | $-0.690 |
FY | 2022 |
収益: | $299.49M |
総利益: | $134.50M (44.91 %) |
EPS: | $-0.690 |
FY | 2022 |
収益: | $271.89M |
総利益: | $132.95M (48.90 %) |
EPS: | $-0.600 |
FY | 2021 |
収益: | $243.92M |
総利益: | $117.01M (47.97 %) |
EPS: | $-0.398 |
Financial Reports:
No articles found.
23andMe Holding Co.
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications based on genetic testing of a saliva sample through its spit kit. The Therapeutics segment focuses on the drug development; and discovery and development of novel therapies to improve patient lives across various therapeutic areas, including oncology, respiratory, and cardiovascular diseases, as well as offers out-licensing of intellectual property associated with identified drug targets related to drug candidates under clinical development. It has a collaboration agreement with GlaxoSmithKline Intellectual Property (No.3) Limited to leverage genetic insights to validate, develop, and commercialize drugs. The company was founded in 2006 and is headquartered in South San Francisco, California.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。